First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies

Overview of attention for article published in Investigational New Drugs, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#26 of 1,286)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 1 blog
twitter: 1 X user

patent: 7 patents
wikipedia: 1 Wikipedia page

Readers on

mendeley: 24 Mendeley

Summary Blogs X Patents Wikipedia

So far, Altmetric has seen 1 X post from an account with 1,265 followers.

@Hbabsthlm @Kemisten84 @Borspodden @Richard_Brase @pharmakillen De "rigorösa vetenskapsmännen" läste nog aldrig peket ordentligt. Det forskarna skriver i sin slutsats till peket https://t.co/3IRR24aPJF kan ni se i bifogad bild. Jag har också modifierat der

Reply Repost Favourite